Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut dysbiosis in Huntington’s disease: associations among gut microbiota, cognitive performance and clinical outcomes
Cory I Wasser, Emily‐Clare Mercieca, Geraldine Kong, et al.
Brain Communications (2020) Vol. 2, Iss. 2
Open Access | Times Cited: 148

Showing 1-25 of 148 citing articles:

Gut–Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions
Suganya Kanmani, Byung‐Soo Koo
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7551-7551
Open Access | Times Cited: 235
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 219
Microbiota medicine: towards clinical revolution
Prisca Gebrayel, Carole Nicco, Souhaila Al Khodor, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 193
Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle
Saravana Babu Chidambaram, Musthafa Mohamed Essa, Annan Gopinath Rathipriya, et al.
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107988-107988
Open Access | Times Cited: 121
Implications of Gut Microbiota in Neurodegenerative Diseases
Haoming Zhang, Yijia Chen, Zifan Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 102
The gut microbiome and mental health: advances in research and emerging priorities
Andrew Shoubridge, Jocelyn M. Choo, Alyce M. Martin, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 4, pp. 1908-1919
Closed Access | Times Cited: 81
Current and Possible Future Therapeutic Options for Huntington’s Disease
Mackenzie Wendy Ferguson, Connor J. Kennedy, Thulani H. Palpagama, et al.
Journal of Central Nervous System Disease (2022) Vol. 14
Open Access | Times Cited: 80
Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome
Brian Bicknell, Ann Liebert, Thomas J. Borody, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9577-9577
Open Access | Times Cited: 65
The Role of Fecal Microbiota Transplantation in the Treatment of Neurodegenerative Diseases: A Review
Julie-Anne Therese Matheson, R. M. Damian Holsinger
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1001-1001
Open Access | Times Cited: 57
Role of Gut Microbiota in Neurological Disorders and Its Therapeutic Significance
Prabhakar Tiwari, Rekha Dwivedi, Manisha Bansal, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1650-1650
Open Access | Times Cited: 49
Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
Yuanyuan Ma, Xin Li, Jin‐Tai Yu, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 19
The microbiota–gut–brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets
Millicent N. Ekwudo, Carolina Gubert, Anthony J. Hannan
FEBS Journal (2024)
Open Access | Times Cited: 18
Altered Gut Microbiota Related to Inflammatory Responses in Patients With Huntington’s Disease
Gang Du, Wei Dong, Qing Yang, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 95
Neurodegenerative disorders and gut-brain interactions
Alpana Singh, Ted M. Dawson, Subhash Kulkarni
Journal of Clinical Investigation (2021) Vol. 131, Iss. 13
Open Access | Times Cited: 83
The microbiota–microglia axis in central nervous system disorders
Omar Mossad, Daniel Erny
Brain Pathology (2020) Vol. 30, Iss. 6, pp. 1159-1177
Open Access | Times Cited: 81
An integrated metagenomics and metabolomics approach implicates the microbiota-gut-brain axis in the pathogenesis of Huntington's disease
Geraldine Kong, Susan Ellul, Vinod K. Narayana, et al.
Neurobiology of Disease (2020) Vol. 148, pp. 105199-105199
Open Access | Times Cited: 78
Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut to the Brain
Haoming Xu, Hong‐Li Huang, Youlian Zhou, et al.
Gastroenterology Research and Practice (2021) Vol. 2021, pp. 1-20
Open Access | Times Cited: 74
The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
Benedetta Parodi, Nicole Kerlero de Rosbo
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 69
Dysbiosis of Gut Microbiota from the Perspective of the Gut–Brain Axis: Role in the Provocation of Neurological Disorders
Meenakshi Kandpal, Omkar Indari, Budhadev Baral, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1064-1064
Open Access | Times Cited: 67
Gut–Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders
Alma Rosa Lezama Toledo, Germán Rivera Monroy, Félipe Esparza Salazar, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1184-1184
Open Access | Times Cited: 61
The Role of a Gut Microbial-Derived Metabolite, Trimethylamine N-Oxide (TMAO), in Neurological Disorders
Sankar Simla Praveenraj, Sharma Sonali, Nikhilesh Anand, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 11, pp. 6684-6700
Closed Access | Times Cited: 51
Bile acids and neurological disease
Michael J. Hurley, Rachel Bates, Jane Macnaughtan, et al.
Pharmacology & Therapeutics (2022) Vol. 240, pp. 108311-108311
Open Access | Times Cited: 43
The Gut Microbiome–Brain Crosstalk in Neurodegenerative Diseases
Laura Ghezzi, Claudia Cantoni, Emanuela Rotondo, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1486-1486
Open Access | Times Cited: 41
Linking circadian rhythms to microbiome-gut-brain axis in aging-associated neurodegenerative diseases
Wai‐Yin Cheng, YS Ho, Raymond Chuen‐Chung Chang
Ageing Research Reviews (2022) Vol. 78, pp. 101620-101620
Closed Access | Times Cited: 39
A Multi-Strain Probiotic Formulation Improves Intestinal Barrier Function by the Modulation of Tight and Adherent Junction Proteins
Raffaella di Vito, Carmela Conte, Giovanna Traina
Cells (2022) Vol. 11, Iss. 16, pp. 2617-2617
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top